Profil
Greg Troiano formerly worked at Translate Bio, Inc., as Chief Manufacturing Officer in 2021.
Mr. Troiano received his undergraduate degree and graduate degree from The Johns Hopkins University.
Ehemalige bekannte Positionen von Greg Troiano
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 14.09.2021 |
Ausbildung von Greg Troiano
| The Johns Hopkins University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
